FDA Inspection 995774 — Rhode Island Blood Center, A Division of New York Blood Center, Inc.
The FDA completed an inspection of Rhode Island Blood Center, A Division of New York Blood Center, Inc. on November 7, 2016 in Providence, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 7, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Providence, RI (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 154 | 21 CFR 606.160(a)(1) | Concurrent documentation |